These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32595511)

  • 1. Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
    Kim HY; Märtson AG; Dreesen E; Spriet I; Wicha SG; McLachlan AJ; Alffenaar JW
    Front Pharmacol; 2020; 11():894. PubMed ID: 32595511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical Performance of Nonlinear Mixed-Effect Models Incorporating Saliva as an Alternative Sampling Matrix for Therapeutic Drug Monitoring in Pediatrics: A Simulation Study.
    Kruizinga MD; Stuurman FE; Driessen GJA; Cohen AF; Bergmann KR; van Esdonk MJ
    Ther Drug Monit; 2021 Aug; 43(4):546-554. PubMed ID: 34250966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Drugs TDM: Trends and Update.
    Kably B; Launay M; Derobertmasure A; Lefeuvre S; Dannaoui E; Billaud EM
    Ther Drug Monit; 2022 Feb; 44(1):166-197. PubMed ID: 34923544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
    Gómez-López A
    Clin Microbiol Infect; 2020 Nov; 26(11):1481-1487. PubMed ID: 32535150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.
    Decosterd LA; Rochat B; Pesse B; Mercier T; Tissot F; Widmer N; Bille J; Calandra T; Zanolari B; Marchetti O
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5303-15. PubMed ID: 20855739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
    Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
    Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
    Liu P; Mould DR
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4718-26. PubMed ID: 24913161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study.
    Samb A; Kruizinga M; Tallahi Y; van Esdonk M; van Heel W; Driessen G; Bijleveld Y; Stuurman R; Cohen A; van Kaam A; de Haan TR; Mathôt R
    Br J Clin Pharmacol; 2022 Feb; 88(4):1845-1855. PubMed ID: 34625981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C; Constance JE; Roberts JK; Olson J; Doby EH; Ampofo K; Stiers J; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
    Bellmann R; Smuszkiewicz P
    Infection; 2017 Dec; 45(6):737-779. PubMed ID: 28702763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal agents in children.
    Steinbach WJ
    Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
    Arendrup MC; Friberg N; Mares M; Kahlmeter G; Meletiadis J; Guinea J;
    Clin Microbiol Infect; 2020 Nov; 26(11):1464-1472. PubMed ID: 32562861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
    Vanstraelen K; Maertens J; Augustijns P; Lagrou K; de Loor H; Mols R; Annaert P; Malfroot A; Spriet I
    Clin Pharmacokinet; 2015 Nov; 54(11):1151-60. PubMed ID: 25910879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
    Niwa T; Imagawa Y; Yamazaki H
    Curr Drug Metab; 2014; 15(7):651-79. PubMed ID: 25429674
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antifungal susceptibility of clinically isolated invasive
    Wan FF; Zhang M; Guo J; Wu WJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1542-1549. PubMed ID: 37859369
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
    Gastine S; Lehrnbecher T; Müller C; Farowski F; Bader P; Ullmann-Moskovits J; Cornely OA; Groll AH; Hempel G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry.
    Shen T; Liu P; Chen D; Liu D; Fang J; Wang Q; Xu Y; Tan C; Wang C
    J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38440953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.